Home treatment with subcutaneous immunoglobulin infusion to children with primary immunodeficiency disease; the role of the nurse

被引：0
|
作者：
Halvorsen, K. [1 ]
Sandersen, H. [1 ]
Lynum, M. B. [1 ]
Abrahamsen, T. G. [1 ,2 ]
机构：
[1] Rikshosp Univ Hosp, Div Paediat, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2008年 / 154卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [11] Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases
    Wasserman, Richard L.
    IMMUNOTHERAPY, 2017, 9 (12) : 1035 - 1050
  • [12] INTRAVENOUS IMMUNOGLOBULIN HOME TREATMENT FOR PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
    OCHS, HD
    FISCHER, SH
    LEE, ML
    DELSON, ES
    KINGDON, HS
    WEDGWOOD, RJ
    LANCET, 1986, 1 (8481): : 610 - 611
  • [13] Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency
    Gupta, Sudhir
    Kobayashi, Roger H.
    Litzman, Jiri
    Cherwin, Laurel
    Hoeller, Sonja
    Kreuwel, Huub
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 7 - 17
  • [14] SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN IN THE TREATMENT OF AGAMMAGLOBULINEMIA
    UGAZIO, AG
    DUSE, M
    RE, R
    MARSEGLIA, GL
    MANGILLI, G
    BENFANTE, A
    BURGIO, GR
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1982, 8 (04): : 675 - 675
  • [15] Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
    Sudhir Gupta
    James DeAngelo
    Isaac Melamed
    Jolan E. Walter
    Ai-Lan Kobayashi
    Tracy Bridges
    J. Wesley Sublett
    Jonathan A. Bernstein
    Alan Koterba
    Michael Manning
    Joanna Maltese
    Sonja Hoeller
    Eva Turpel-Kantor
    Huub Kreuwel
    Roger H. Kobayashi
    Journal of Clinical Immunology, 2023, 43 : 1414 - 1425
  • [16] Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
    Gupta, Sudhir
    DeAngelo, James
    Melamed, Isaac
    Walter, Jolan E. E.
    Kobayashi, Ai-Lan
    Bridges, Tracy
    Sublett, J. Wesley
    Bernstein, Jonathan A. A.
    Koterba, Alan
    Manning, Michael
    Maltese, Joanna
    Hoeller, Sonja
    Turpel-Kantor, Eva
    Kreuwel, Huub
    Kobayashi, Roger H. H.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1414 - 1425
  • [17] Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
    Jolles, Stephen
    IMMUNOTARGETS AND THERAPY, 2013, 2 : 125 - 133
  • [18] Advantage of subcutaneous infusion immunoglobulin replacement home therapy
    Cimbollek, S.
    Gonzalez-Quevedo, T.
    Avila, M.
    Diaz, M.
    ALLERGY, 2008, 63 : 475 - 476
  • [19] Delivery of subcutaneous immunoglobulin by rapid "push" infusion for primary immunodeficiency patients in Manitoba: a retrospective review
    Walter, Graham
    Kalicinsky, Chrystyna
    Warrington, Richard
    Miguel, Marianne
    Reyes, Jeannette
    Rubin, Tamar S.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):
  • [20] Subcutaneous immunoglobulin in primary immunodeficiency - impact of training and infusion characteristics on patient-reported outcomes
    Mallick, R.
    Henderson, T.
    Lahue, B. J.
    Kafal, A.
    Bassett, P.
    Scalchunes, C.
    BMC IMMUNOLOGY, 2020, 21 (01)
12345